Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cystic lymphangioma
ADR ID BADD_A08395
ADR Hierarchy
01      Blood and lymphatic system disorders
01.09      Spleen, lymphatic and reticuloendothelial system disorders
01.09.01      Lymphatic system disorders NEC
01.09.01.022      Cystic lymphangioma
03      Congenital, familial and genetic disorders
03.15      Blood and lymphatic system disorders congenital
03.15.05      Lymphatic system disorders congenital
03.15.05.002      Cystic lymphangioma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.18      Soft tissue neoplasms benign
16.18.01      Soft tissue neoplasms benign NEC
16.18.01.005      Cystic lymphangioma
Description A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin. [MeSH]
MedDRA Code 10058949
MeSH ID D018191; D018191; D018191
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cystic hygroma | Hygroma cystic | Cystic lymphangioma | Lymphangioma, Cystic | Cystic Lymphangioma | Cystic Lymphangiomas | Lymphangiomas, Cystic | Hygroma, Cystic | Cystic Hygroma | Cystic Hygromas | Hygromas, Cystic | Cystic Hygroma Colli | Colli, Cystic Hygroma | Hygroma Colli, Cystic | Hygroma | Hygromas
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01265Levetiracetam0.000381%
BADD_D01617Ondansetron0.000100%
BADD_D01835Pregabalin0.000236%
BADD_D02010Sertraline0.000212%
The 1th Page    1    Total 1 Pages